These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38663768)

  • 1. Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines.
    Meyers G; Bubalo J; Eckstrom E; Winsnes K; Carpenter PA; Artz A; Lin RJ
    Transplant Cell Ther; 2024 Jul; 30(7):646-662. PubMed ID: 38663768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
    Vergara-Cadavid J; Johnson PC; Kim HT; Yi A; Sise ME; Leaf DE; Hanna PE; Ho VT; Cutler CS; Antin JH; Gooptu M; Kelkar AH; Wells SL; Nikiforow S; Koreth J; Romee R; Soiffer RJ; Shapiro RM; Gupta S
    Transplant Cell Ther; 2023 Jul; 29(7):455.e1-455.e9. PubMed ID: 37015320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Neuroimaging Correlates of Post-Transplant Delirium.
    Smith P; Thompson JC; Perea E; Wasserman B; Bohannon L; Racioppi A; Choi T; Gasparetto C; Horwitz ME; Long G; Lopez R; Rizzieri DA; Sarantopoulos S; Sullivan KM; Chao NJ; Sung AD
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2323-2328. PubMed ID: 32961373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.
    Kanate AS; Majhail NS; Savani BN; Bredeson C; Champlin RE; Crawford S; Giralt SA; LeMaistre CF; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Veys PA; Carpenter PA; Hamadani M
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1247-1256. PubMed ID: 32165328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Wenger DS; Triplette M; Crothers K; Cheng GS; Hill JA; Milano F; Shahrir S; Schoch G; Vande Vusse LK
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):413-420. PubMed ID: 31605819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation.
    Rotz SJ; Hamilton BK; Wei W; Ahmed I; Winston SA; Ballard S; Bernard RJ; Carpenter P; Farhadfar N; Ferraro C; Friend BD; Gloude NJ; Hayashi RJ; Hoyle K; Jenssen K; Koo J; Lee CJ; Mariano L; Nawabit R; Ngwube A; Lalefar N; Phelan R; Perkins L; Rao A; Rayes A; Sandheinrich T; Stafford L; Tomlinson K; Whiteside S; Wiedl C; Myers K
    Transplant Cell Ther; 2024 May; 30(5):534.e1-534.e13. PubMed ID: 38342136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation.
    Hoodin F; LaLonde L; Errickson J; Votruba K; Kentor R; Gatza E; Reddy P; Choi SW
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):343-353. PubMed ID: 30244099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delirium and Healthcare Utilization in Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Amonoo HL; Markovitz NH; Johnson PC; Kwok A; Dale C; Deary EC; Daskalakis E; Choe JJ; Yamin N; Gothoskar M; Cronin KG; Fernandez-Robles C; Pirl WF; Chen YB; Cutler C; Lindvall C; El-Jawahri A
    Transplant Cell Ther; 2023 May; 29(5):334.e1-334.e7. PubMed ID: 36736782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women.
    Lee YJ; Kim JS; Jo JC; Kim Y; Im HS; Kim H; Koh S; Min YJ; Park SH; Ahn JW; Choi Y
    Eur J Haematol; 2023 Sep; 111(3):449-457. PubMed ID: 37308461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study.
    Bulthuis MS; van Leeuwen SJM; Thomas RZ; van Gennip LLA; Whiteside HM; Isom S; Kline DM; Laheij AMGA; Raber-Durlacher JE; Hasséus B; Johansson JE; Hovan AJ; Brennan MT; von Bültzingslöwen I; Huysmans MDNJM; Blijlevens NMA
    Transplant Cell Ther; 2024 Apr; 30(4):446.e1-446.e11. PubMed ID: 38242439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.
    Sharafeldin N; Bosworth A; Patel SK; Chen Y; Morse E; Mather M; Sun C; Francisco L; Forman SJ; Wong FL; Bhatia S
    J Clin Oncol; 2018 Feb; 36(5):463-475. PubMed ID: 29252122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant.
    Basinski JR; Alfano CM; Katon WJ; Syrjala KL; Fann JR
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):824-31. PubMed ID: 20100587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
    Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
    Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis.
    Abdul Wahid SF; Ismail NA; Mohd-Idris MR; Jamaluddin FW; Tumian N; Sze-Wei EY; Muhammad N; Nai ML
    Stem Cells Dev; 2014 Nov; 23(21):2535-52. PubMed ID: 25072307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
    Nakamae H; Kirby KA; Sandmaier BM; Norasetthada L; Maloney DG; Maris MB; Davis C; Corey L; Storb R; Boeckh M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):694-703. PubMed ID: 19450754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.